|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Verrica Pharmaceuticals (NASDAQ: VRCA) through any online brokerage.
The latest price target for Verrica Pharmaceuticals (NASDAQ: VRCA) was reported by HC Wainwright & Co. on September 22, 2021. The analyst firm set a price target for 20.00 expecting VRCA to rise to within 12 months (a possible 61.16% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $12.41 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Verrica Pharmaceuticals.
Verrica Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Verrica Pharmaceuticals.
Verrica Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.